Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|July 21, 2020
Biosimilars in psoriasis: what should your positioning be?Ricardo Ruiz-Villaverde, Manuel Galán-GutierrezAustralian Family Physician|August 5, 2011
Green concretions on the left axillaeRicardo Ruiz-Villaverde, Daniel Sánchez-Cano, Manuel Galán-GutierrezThe Journal of Dermatological Treatment|June 19, 2015
Efficacy and cost of etanercept in long-term psoriasis: Rational use in clinical practiceRicardo Ruiz-Villaverde, Manuel Galán-Gutierrez, Roman Barabash-Neila, et al.International Journal of Dermatology|March 17, 2020
Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective studyRicardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Manuel Galán-Gutierrez, et al.Journal of Clinical Medicine|February 13, 2025
Comparative Analysis of Ixekizumab Effectiveness with and Without Induction Therapy in Moderate-to-Severe Psoriasis: A Real-World StudyRicardo Ruiz-Villaverde, Pedro José Ezomo-Gervilla, Jose Molina-Espinosa, et al.The American Journal of Dermatopathology|July 22, 2016
Histological Features, p53, c-Kit, and Poliomavirus Status and Impact on Survival in Merkel Cell Carcinoma PatientsHusein Husein-ElAhmed, Francisco Ramos-Pleguezuelos, Inmaculada Ruiz-Molina, et al.Pageof 1